1. Copyright © 2007 American Medical Association. All rights reserved.
From: Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyA Systematic Review
JAMA. 2007;297(23): doi: /jama
Figure Legend:
In the study by Shulman et al, the number of sulfadoxine-pyrimethamine (or placebo) doses depended on gestational age at enrollment; the majority of women (64%) received 2 doses. The size of the square data markers reflects the relative weight of each study. The diamonds represent summary effect estimates. CI indicates confidence interval.*Indicates random-effects model was used.†Indicates fixed-effects model was used.
Date of download: 10/23/2017
Copyright © 2007 American Medical Association. All rights reserved.

2. Copyright © 2007 American Medical Association. All rights reserved.
From: Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyA Systematic Review
JAMA. 2007;297(23): doi: /jama
Figure Legend:
Both studies were conducted in areas of low to moderate sulfadoxine-pyrimethamine treatment failure among symptomatic children by day 14 (3% and 5%). However, chloroquine treatment failure in children was much lower in Mali (8.9% at day 7) than in Malawi (85.7% at day 7). The effect on mean birth weight, hemoglobin level, and anemia were reported only for the study in Mali (not shown). The size of the square data markers reflects the relative weight of each study. The diamonds represent summary effect estimates. CI indicates confidence interval; RR, relative risk.*Indicates random-effects model was used.†Indicates fixed-effects model was used.
Date of download: 10/23/2017
Copyright © 2007 American Medical Association. All rights reserved.

3. Copyright © 2007 American Medical Association. All rights reserved.
From: Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyA Systematic Review
JAMA. 2007;297(23): doi: /jama
Figure Legend:
Only data from women during their first or second pregnancy are presented from the study by Hamer et al (unpublished) to allow comparison with the other 2 studies. The size of the square data markers reflects the relative weight of each study. The diamonds represent summary effect estimates. CI indicates confidence interval; HIV, human immunodeficiency virus; RR, relative risk.*Indicates fixed-effects model was used.†Indicates random-effects model was used
Date of download: 10/23/2017
Copyright © 2007 American Medical Association. All rights reserved.

4. Copyright © 2007 American Medical Association. All rights reserved.
From: Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyA Systematic Review
JAMA. 2007;297(23): doi: /jama
Figure Legend:
In the study by Shulman et al, the number of sulfadoxine-pyrimethamine (or placebo) doses depended on gestational age at enrollment; the majority of women (64%) received 2 doses. The size of the square data markers reflects the relative weight of each study. The diamonds represent summary effect estimates. CI indicates confidence interval; RR, relative risk.*Indicates random-effects model was used.†Indicates fixed-effects model was used.‡Hemoglobin level lower than 10 g/dL or lower than 11 g/dL.
Date of download: 10/23/2017
Copyright © 2007 American Medical Association. All rights reserved.

5. Copyright © 2007 American Medical Association. All rights reserved.
From: Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyA Systematic Review
JAMA. 2007;297(23): doi: /jama
Figure Legend:
Only data from women during their first or second pregnancy are presented from the study by Hamer et al (unpublished) to allow comparison with the other 2 studies. The size of the square data markers reflects the relative weight of each study. The diamonds represent summary effect estimates. CI indicates confidence interval; HIV, human immunodeficiency virus.
Date of download: 10/23/2017
Copyright © 2007 American Medical Association. All rights reserved.

6. Copyright © 2007 American Medical Association. All rights reserved.
From: Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyA Systematic Review
JAMA. 2007;297(23): doi: /jama
Figure Legend:
The reduction in the proportion of women with peripheral parasitemia is calculated as the percentage of women with peripheral parasitemia at enrollment minus the percentage with peripheral parasitemia at delivery divided by the percentage of peripheral parasitemia at enrollment divided by 100. The reference numbers in the figure indicate the reference of the trial (first number) and the reference of the matching study among children (numbers in parentheses). HIV indicates human immunodeficiency virus.*The study population is pregnant women who are younger than 21 years during their first or second pregnancy.†Women randomized to insecticide-treated nets were excluded.‡Resistance to sulfadoxine-pyrimethamine was defined as the proportion of total treatment failure in symptomatic children by day 14.
Date of download: 10/23/2017
Copyright © 2007 American Medical Association. All rights reserved.